Type 2 Diabetes Mellitus and Hearing Loss: A Prisma Systematic Review and Meta‐Analysis
Typ-2-Diabetes mellitus und Hörverlust: systematische PRISMA-Übersicht und Metaanalyse
Otolaryngology–Head and Neck Surgery · 2025-11 · 173 (5) · 1041-1053
DOI: 10.1002/ohn.1346 ↗Auf einen Blick
Die Metaanalyse fand bei Typ-2-Diabetes eine höhere Hörverlustprävalenz als in Kontrollen. Die Hörschwellen waren besonders bei hohen Frequenzen erhöht.
Fragestellung
Besteht ein Zusammenhang zwischen Typ-2-Diabetes und Hörverlust?
Methode
Systematische Übersicht und Metaanalyse; Suche in PubMed und Scopus für Artikel von Januar 2019 bis April 2024; Bewertung mit Newcastle-Ottawa-Skala und Cochrane Review Manager.
Ergebnisse
17 Studien erfüllten die Kriterien. Hörverlust: 40,6 % bis 71,9 % bei Typ-2-Diabetes; OR 4,19 (95 %-KI 1,22–14,37) vs. Kontrollen. Hörschwellen 3,19 dB höher.
Schlussfolgerung der Autor:innen
Die Prävalenz von Hörverlust bei Typ-2-Diabetes liegt zwischen 40,6 % und 71,9 %. Das Risiko ist im Vergleich zu Kontrollen 4,19-fach höher und betrifft vor allem hohe Frequenzen.
Kernaussagen
- Hörverlust bei Typ-2-Diabetes häufiger als bei Kontrollen
- OR 4,19 (95 %-KI 1,22–14,37)
- Hörschwellen besonders bei hohen Frequenzen erhöht
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
At a glance
Systematische Übersicht in Otolaryngology–Head and Neck Surgery, published online on 2025-09-08. Written by Miguel Caballero-Borrego and 1 co-authors. Institution: Department of Otorhinolaryngology, Hospital Clínic, Barcelona, Spain. Major MEDLINE topics: Diabetes Mellitus, Type 2, Hearing Loss. Cited 13 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY 4.0).
Topics: Diabetes mellitus
Abstract (original language)
Objective
To conduct a systematic review and meta‐analysis to assess the association between type 2 diabetes and hearing loss. Data Sources Search conducted in PubMed and Scopus databases for articles published between January 2019 and April 2024. Review Methods Quality assessment and risk of bias analysis were conducted using the Newcastle‐Ottawa scale, and meta‐analyses of pooled data were performed with Cochrane's Review Manager.
Results
From 8354 initially identified articles, 17 met the inclusion criteria. The prevalence of hearing loss in patients with type 2 diabetes range from 40.6% to 71.9%, which was significantly higher than in controls (odds ratio [OR]: 4.19; 95% confidence interval [CI]: 1.22‐14.37). The mean pure‐tone audiometric thresholds of the diabetic group were 3.19 dB higher (95% CI: 1.08‐5.19) and were higher for both low frequencies (1.11 dB, 95% CI: 0.62‐1.57) and, more severely, for high frequencies (2.3 dB, 95% CI: 1.97‐2.63). Patients with moderate (0.57%, 95% CI: 0.1‐1.05) and severe‐to‐profound (0.95%, 95% CI: 0.02‐1.87) hearing loss had higher mean HbA1c levels than controls. The prevalence of hearing loss was significantly higher among patients with a diagnosis of diabetes for more than 10 years (OR 2.07, 95% CI: 1.45‐2.94). The gender of diabetic patients was found to have no influence.
Conclusion
The prevalence of hearing loss among individuals with type 2 diabetes ranges from 40.6% to 71.9%. Compared to the control group, the risk of hearing loss is 4.19 times higher and is predominantly observed at higher frequencies. The duration of diabetes and HbA1c levels are significant factors in the prevalence of hearing loss.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Otorhinolaryngology, Hospital Clínic, Barcelona, Spain.
- Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
- Systemic Autoimmune Diseases research group, Institut d'Investigació Biomèdica August Pi Sunyer (IDIBAPS), Barcelona, Spain.
ORCID profiles: Miguel Caballero-Borrego
Cite
APA
Caballero-Borrego, M., & Andujar-Lara, I. (2025). Type 2 Diabetes Mellitus and Hearing Loss: A Prisma Systematic Review and Meta‐Analysis. Otolaryngology–Head and Neck Surgery, 173(5), 1041-1053. https://doi.org/10.1002/ohn.1346
Vancouver
Caballero-Borrego M, Andujar-Lara I. Type 2 Diabetes Mellitus and Hearing Loss: A Prisma Systematic Review and Meta‐Analysis. Otolaryngology–Head and Neck Surgery. 2025;173(5):1041-1053. doi:10.1002/ohn.1346
BibTeX
@article{CaballeroBorrego2025,
author = {Caballero-Borrego, Miguel and Andujar-Lara, Ivan},
title = {Type 2 Diabetes Mellitus and Hearing Loss: A Prisma Systematic Review and Meta‐Analysis},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
volume = {173},
number = {5},
pages = {1041--1053},
doi = {10.1002/ohn.1346}
}
EUVIMED